Hudson Bay Capital Management LP Takes $3.93 Million Position in Sotera Health Company $SHC

Hudson Bay Capital Management LP bought a new stake in Sotera Health Company (NASDAQ:SHC) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 250,000 shares of the company’s stock, valued at approximately $3,932,000. Hudson Bay Capital Management LP owned about 0.09% of Sotera Health as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently bought and sold shares of SHC. Arizona State Retirement System grew its stake in Sotera Health by 1.4% in the third quarter. Arizona State Retirement System now owns 46,183 shares of the company’s stock valued at $726,000 after purchasing an additional 621 shares in the last quarter. Legal & General Group Plc boosted its holdings in shares of Sotera Health by 0.5% in the 3rd quarter. Legal & General Group Plc now owns 255,526 shares of the company’s stock valued at $4,019,000 after buying an additional 1,252 shares during the last quarter. California State Teachers Retirement System boosted its holdings in shares of Sotera Health by 0.9% in the 3rd quarter. California State Teachers Retirement System now owns 145,318 shares of the company’s stock valued at $2,286,000 after buying an additional 1,315 shares during the last quarter. Versant Capital Management Inc grew its stake in shares of Sotera Health by 117.6% in the third quarter. Versant Capital Management Inc now owns 2,535 shares of the company’s stock valued at $40,000 after buying an additional 1,370 shares in the last quarter. Finally, Federated Hermes Inc. grew its stake in shares of Sotera Health by 9.9% in the third quarter. Federated Hermes Inc. now owns 15,732 shares of the company’s stock valued at $247,000 after buying an additional 1,423 shares in the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $15.27, for a total value of $152,700,000.00. Following the completion of the sale, the director owned 12,735,301 shares of the company’s stock, valued at approximately $194,468,046.27. The trade was a 43.98% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 47.55% of the company’s stock.

Sotera Health Price Performance

Shares of NASDAQ SHC opened at $13.50 on Friday. The firm has a market cap of $3.84 billion, a P/E ratio of 50.00 and a beta of 1.84. The business’s 50 day moving average is $16.83 and its 200-day moving average is $16.66. The company has a current ratio of 2.46, a quick ratio of 2.24 and a debt-to-equity ratio of 3.66. Sotera Health Company has a 1-year low of $9.53 and a 1-year high of $19.85.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. Sotera Health had a return on equity of 42.38% and a net margin of 6.70%.The business had revenue of $303.44 million during the quarter, compared to analysts’ expectations of $300.68 million. During the same period last year, the firm posted $0.21 EPS. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. Equities research analysts predict that Sotera Health Company will post 0.61 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on SHC shares. Wells Fargo & Company lowered shares of Sotera Health to an “overweight” rating in a research report on Thursday, January 8th. William Blair started coverage on shares of Sotera Health in a research note on Thursday, December 18th. They set an “outperform” rating on the stock. Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Piper Sandler upgraded shares of Sotera Health from a “neutral” rating to an “overweight” rating and raised their target price for the company from $17.00 to $24.00 in a research note on Friday, January 9th. Finally, Citigroup lifted their price target on Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $20.43.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.